Literature DB >> 1420675

Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin.

D J Baumgardner1, B P Buggy, B J Mattson, J S Burdick, D Ludwig.   

Abstract

The clinical and epidemiologic features of 73 patients with laboratory-confirmed blastomycosis who were identified over an 11-year period in North Central Wisconsin are presented. Pulmonary disease was the sole manifestation in 77% of patients. More than one-half of all patients had symptoms that included fever, cough, weight loss, night sweats, and pleuritic chest pain. Virtually all were previously healthy, and most did not have an outdoor occupation. However, 82% of these patients lived or had visited within 500 m of rivers or associated waterways. The majority experienced the onset of symptoms between December and April. The estimated mean annual incidence rate of infection for Vilas County was 40.4 cases per 100,000 persons, and that for the largest city in the county was 101.3 cases per 100,000 persons. Several areas with an exceptionally high incidence of the infection were observed. We suggest that, in regions where blastomycosis is hyperendemic, clinical disease is most often pulmonary and occurs in immunocompetent individuals and that residence near an ecological focus may be a greater risk factor for acquisition of blastomycosis than is occupation.

Entities:  

Mesh:

Year:  1992        PMID: 1420675     DOI: 10.1093/clind/15.4.629

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds.

Authors:  Dennis J Baumgardner; Erica M Knavel; Dale Steber; Geoffrey R Swain
Journal:  Mycopathologia       Date:  2006-05       Impact factor: 2.574

2.  Cutaneous manifestations of endemic mycoses.

Authors:  Jeannina A Smith; James Riddell; Carol A Kauffman
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

3.  Genetic diversity and transcriptional analysis of the bys1 gene from Blastomyces dermatitidis.

Authors:  J L Bono; B Jaber; M A Fisher; R O Abuodeh; E O'Leary-Jepson; G M Scalarone; L H Smith
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

4.  The differential diagnosis of pulmonary blastomycosis using case vignettes: a Wisconsin Network for Health Research (WiNHR) study.

Authors:  Dennis J Baumgardner; Jonathan L Temte; Erin Gutowski; William A Agger; Howard Bailey; James K Burmester; Indrani Banerjee
Journal:  WMJ       Date:  2011-04

5.  Analysis and modeling of Blastomyces dermatitidis environmental prevalence in Minnesota using soil collected to compare basal and outbreak levels.

Authors:  Katrina M Jackson; Keith C Pelletier; Joni Scheftel; Joshua D Kerkaert; Serina L Robinson; Tami McDonald; Jeff B Bender; Joseph F Knight; Malia Ireland; Kirsten Nielsen
Journal:  Appl Environ Microbiol       Date:  2020-12-18       Impact factor: 4.792

Review 6.  The endemic mimic: blastomycosis an illness often misdiagnosed.

Authors:  Robert W Bradsher
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

7.  Unexpected Blastomyces dermatitidis etiology of fungal sinusitis and erosive palatal infection in a diabetic patient.

Authors:  Jane Thomas; Erik Munson; John C Christianson
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

8.  An imported case of Blastomyces dermatitidis infection in Mexico.

Authors:  Roberto Velázquez; B Muñoz-Hernández; R Arenas; M L Taylor; F Hernández-Hernández; M E Manjarrez; R López-Martínez
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

9.  Blastomycosis acquired by three children in Toronto.

Authors:  Stacey Bernstein; Hermine I Brunner; Richard Summerbell; Upton Allen; Paul Babyn; Susan E Richardson
Journal:  Can J Infect Dis       Date:  2002-07

10.  Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis.

Authors:  Holly M Frost; Thomas J Novicki
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.